Syndecan-1 mediates internalization of apoE-VLDL through a low density lipoprotein receptor-related protein (LRP)-independent, non-clathrin-mediated pathway
about
Molecular processes that handle -- and mishandle -- dietary lipidsSyndecan-1 is the primary heparan sulfate proteoglycan mediating hepatic clearance of triglyceride-rich lipoproteins in miceLDL receptor and its family members serve as the cellular receptors for vesicular stomatitis virusGuanidinylated neomycin mediates heparan sulfate-dependent transport of active enzymes to lysosomes.Syndecan-1 is required to maintain intradermal fat and prevent cold stress.Clathrin-independent endocytosis: a cargo-centric viewApolipoprotein E in synaptic plasticity and Alzheimer's disease: potential cellular and molecular mechanisms.Shedding of syndecan-1 from human hepatocytes alters very low density lipoprotein clearance.Syndecan-1 antigen, a promising new target for triple-negative breast cancer immuno-PET and radioimmunotherapy. A preclinical study on MDA-MB-468 xenograft tumorsApolipoproteins E and AV mediate lipoprotein clearance by hepatic proteoglycansSyndecan-4 mediates macrophage uptake of group V secretory phospholipase A2-modified LDL.6-o- and N-sulfated syndecan-1 promotes baculovirus binding and entry into Mammalian cells.The signaling mechanisms of syndecan heparan sulfate proteoglycans.The productive entry pathway of HIV-1 in macrophages is dependent on endocytosis through lipid rafts containing CD4.Syndecan-1: an inhibitor of arterial smooth muscle cell growth and intimal hyperplasia.Hepatic and Aortic Arch Expression and Serum Levels of Syndecan-1 in ApoE-/- Mice.Roles of EXTL2, a member of the EXT family of tumour suppressors, in liver injury and regeneration processes.HS3ST2 expression is critical for the abnormal phosphorylation of tau in Alzheimer's disease-related tau pathology.Identification of key genes and pathways in uterine leiomyosarcoma through bioinformatics analysis.
P2860
Q24642118-CCFE17FC-A4F2-47FE-8611-B78A961BA5B2Q24647376-3C16AB41-FC25-469F-8174-E32364C33EC6Q28118448-1A59F0A3-F289-4F3D-BD3C-DB676E166CFAQ30495726-4CEA7D69-BD6F-4C65-A94D-AE102682EB08Q34015240-A77636F2-286F-418A-8ED8-E4AA9EB6B2E7Q34149489-F4147C92-B4D8-4826-84E0-A94F1FF8249FQ34628212-7EBADEF2-9EF3-4D5C-8D28-B9555A6ECA00Q35631767-2772C18C-0115-4C5A-8299-15C916820D45Q35650530-D4E716B7-6AAD-44E6-99C3-4EE32818A28BQ36891073-335756B2-A0CC-4D4D-83A0-78F2C0AE2EA1Q37130793-773B5A22-467F-4560-836B-213E5958357FQ37252596-C229A30D-A168-48B6-BB62-0AD04ED4D413Q37522781-36046F38-C45E-4A1F-B27A-258D23BDC8ABQ39030295-1594BB95-4A1E-4959-B4DE-3E90E5A03954Q42102932-A9217E56-2E6C-46E6-91FC-975AFBF0A88FQ45158054-4843BF91-52A8-4E57-B3D9-C83544278D1DQ46580885-FC808A85-E463-4CF3-8004-E6C4AD635A64Q48246914-B88339F5-41E6-4334-8B23-844763285698Q55342255-60726EA6-022A-4B6C-B75E-23AD83F403E9
P2860
Syndecan-1 mediates internalization of apoE-VLDL through a low density lipoprotein receptor-related protein (LRP)-independent, non-clathrin-mediated pathway
description
2006 nî lūn-bûn
@nan
2006 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Syndecan-1 mediates internaliz ...... non-clathrin-mediated pathway
@ast
Syndecan-1 mediates internaliz ...... non-clathrin-mediated pathway
@en
type
label
Syndecan-1 mediates internaliz ...... non-clathrin-mediated pathway
@ast
Syndecan-1 mediates internaliz ...... non-clathrin-mediated pathway
@en
prefLabel
Syndecan-1 mediates internaliz ...... non-clathrin-mediated pathway
@ast
Syndecan-1 mediates internaliz ...... non-clathrin-mediated pathway
@en
P2093
P2860
P356
P1476
Syndecan-1 mediates internaliz ...... non-clathrin-mediated pathway
@en
P2093
Amanda M Gonzales
Larissa C Wilsie
Robert A Orlando
P2860
P2888
P356
10.1186/1476-511X-5-23
P577
2006-08-31T00:00:00Z
P6179
1026878750